Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Diversified Healthcare Trust (DHC)

Compare
2.5800
-0.1000
(-3.73%)
As of 1:14:07 PM EDT. Market Open.
Loading Chart for DHC
  • Previous Close 2.6800
  • Open 2.6300
  • Bid 2.5700 x 100
  • Ask 2.5800 x 100
  • Day's Range 2.5700 - 2.7500
  • 52 Week Range 2.0100 - 4.2400
  • Volume 197,867
  • Avg. Volume 1,100,293
  • Market Cap (intraday) 622.482M
  • Beta (5Y Monthly) 2.14
  • PE Ratio (TTM) --
  • EPS (TTM) -1.5500
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield 0.04 (1.50%)
  • Ex-Dividend Date Jan 27, 2025
  • 1y Target Est 2.00

DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2023, DHC's approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.6 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA.

www.dhcreit.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DHC

View More

Performance Overview: DHC

Trailing total returns as of 3/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 .

YTD Return

DHC
12.69%
S&P 500
4.36%

1-Year Return

DHC
6.13%
S&P 500
9.79%

3-Year Return

DHC
8.93%
S&P 500
32.06%

5-Year Return

DHC
45.16%
S&P 500
95.17%

Compare To: DHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DHC

View More

Valuation Measures

Annual
As of 3/7/2025
  • Market Cap

    644.20M

  • Enterprise Value

    3.41B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.43

  • Price/Book (mrq)

    0.33

  • Enterprise Value/Revenue

    2.28

  • Enterprise Value/EBITDA

    22.90

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -24.76%

  • Return on Assets (ttm)

    -0.65%

  • Return on Equity (ttm)

    -17.24%

  • Revenue (ttm)

    1.5B

  • Net Income Avi to Common (ttm)

    -370.26M

  • Diluted EPS (ttm)

    -1.5500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    144.58M

  • Total Debt/Equity (mrq)

    149.65%

  • Levered Free Cash Flow (ttm)

    -150.97M

Research Analysis: DHC

View More

Company Insights: DHC

Research Reports: DHC

View More

People Also Watch